Development of Novel Methods for Drug Delivery Using Nanotechnology in Cancer Treatment

Thesis Abstract

Abstract
The treatment of cancer has long been a challenging endeavor due to the complexity and heterogeneity of the disease. Conventional chemotherapy often lacks specificity, leading to significant side effects and limited efficacy. In recent years, nanotechnology has emerged as a promising approach to improve drug delivery in cancer treatment. This thesis focuses on the development of novel methods for drug delivery using nanotechnology to enhance the targeted delivery of anti-cancer agents and improve therapeutic outcomes. Chapter One provides an introduction to the research topic, including the background of the study, problem statement, objectives, limitations, scope, significance, structure of the thesis, and definitions of key terms. The introduction highlights the urgent need for more effective and targeted cancer treatments, setting the stage for the subsequent chapters. Chapter Two presents a comprehensive literature review on nanotechnology-based drug delivery systems in cancer treatment. The review covers various aspects, including the principles of nanotechnology, different types of nanoparticles, advantages of nanocarriers, challenges in drug delivery, and recent advancements in the field. The literature review synthesizes current knowledge to provide a solid foundation for the research methodology. Chapter Three outlines the research methodology employed in this study. It includes details on the research design, materials and methods, data collection techniques, experimental procedures, characterization techniques, and statistical analysis. The chapter also discusses the selection criteria for nanoparticles, drug loading methods, in vitro and in vivo studies, and evaluation of drug release kinetics. Chapter Four presents the findings and results of the research. The chapter discusses the formulation and characterization of novel nanocarriers, drug loading efficiency, release profiles, cellular uptake studies, cytotoxicity assays, and in vivo efficacy evaluations. The results demonstrate the potential of nanotechnology-based drug delivery systems to improve the therapeutic index of anti-cancer drugs and enhance their selective accumulation in tumor tissues. Chapter Five concludes the thesis with a summary of the key findings, implications of the research, and recommendations for future studies. The conclusion highlights the significance of the developed nanocarriers in improving drug delivery efficiency, reducing systemic toxicity, and enhancing the overall therapeutic outcomes in cancer treatment. The thesis contributes to the ongoing efforts to advance nanotechnology-based drug delivery strategies for more effective and targeted cancer therapies. In conclusion, this thesis provides a comprehensive overview of the development of novel methods for drug delivery using nanotechnology in cancer treatment. The research findings underscore the potential of nanocarriers to revolutionize cancer therapy by overcoming existing challenges in drug delivery and improving treatment outcomes. Future research in this area is critical to further optimize nanotechnology-based drug delivery systems and translate them into clinically effective cancer treatments.